Prehabilitation in Gynaecological Cancer Patients (PHOCUS)

  • STATUS
    Recruiting
  • End date
    Jun 30, 2026
  • participants needed
    64
  • sponsor
    Charles University, Czech Republic
Updated on 20 April 2022
cancer
hormone therapy
cancer chemotherapy
ovarian cancer
tumor debulking
ovarian epithelial carcinoma
cancer of the ovary
epithelial ovarian cancer
primary debulking surgery
interval debulking surgery

Summary

Prehabilitation refers to interventions aiming to improve patients' resilience and functional capacity before a known stressful event, e.g., scheduled surgery. These interventions usually consist of physical activity and psychological and nutritional support. There is substantial evidence of the positive effect of multimodal prehabilitation among patients treated surgically for non-gynaecological cancers; however, no prospective data are available in gynaecological cancer patients.

PHOCUS trial is a prospective randomised trial aiming to evaluate the role of multimodal prehabilitation in patients with gynaecological cancer. Sixty-four patients will be randomised in single institution within 36 months with a 1:1 ratio into ARM A: control arm which will be provided with a basic information and standard of care support; ARM B: active arm undergoing multimodal prehabilitation composed of physical activity and psychological and nutritional support. All patients will be assessed at standard intervals (three times during the trial) by a spectrum of non-invasive tests, evaluating physical functional capacity, postoperative morbidity, nutritional status, level of stress and anxiety, and quality of life.

Description

The objective of the trial is to evaluate the impact of intensive multimodal prehabilitation protocol on pre-operative functional capacity, postoperative morbidity, and quality of life in patients undergoing surgical treatment for gynaecological cancer.

Two groups of patients scheduled for postponed surgical treatment will be eligible for the trial: i) advanced ovarian cancer patients referred for neoadjuvant chemotherapy and interval debulking surgery; ii) stage I-II endometrial cancer patients classifying as frail (according to the validated modified Frailty Index), who will be treated by hormonal therapy for three months, followed by surgical treatment.

Details
Condition Ovarian Cancer, Ovarian Cancer Stage III, Ovarian Cancer Stage IV, Endometrial Cancer, Frailty
Treatment psychological intervention, nutritional intervention, Physiological intervention
Clinical Study IdentifierNCT04789694
SponsorCharles University, Czech Republic
Last Modified on20 April 2022

Eligibility

Yes No Not Sure

Inclusion Criteria

Two groups of patients will be eligible for the trial
i) Epithelial ovarian cancer patients referred for NACT: a) FIGO stage III or IV disease
b) Patient is not a candidate for primary debulking surgery; c) Patient is a suitable
candidate for standard of care combined chemotherapy; d) Patient is a candidate for
interval.debulking surgery
ii) Stage I or II endometrial cancer patients classifying as frail according to the
validated modified Frailty Index: a) FIGO stage I or II; b) Patient is classified as frail
c) Patient is suitable candidate for hormonal therapy

Exclusion Criteria

Second malignant tumour (under the treatment)
Patient is not suitable for any surgery delay
Patient is not physically able to meet the prehabilitation intervention plan or is
unable to walk
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note